Injectable Steroid Product Recalled for Lack of Sterility Assurance
Carolina Infusion is recalling its TEST CYP/DHEA injectable steroid vials nationwide because the manufacturer cannot assure they are sterile. The recall affects 348 vials with lot numbers from June-August 2022.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall without reported illnesses or injuries. The hazard—lack of sterility assurance in an injectable product—is a risk-of-harm situation where injury has not yet been reported, meeting the criteria for a High severity score per the rubric.
Plain-English summary
Carolina Infusion LLC is recalling TEST CYP/DHEA (Sesame) 200 MG/2.5 MG/ML Injectable, 10 mL vials, due to lack of assurance of sterility. A total of 348 vials distributed nationwide are affected.
The affected products include multiple lot codes manufactured between June and August 2022, with beyond-use dates between August and November 2022. The FDA has classified this as a Class II recall.
Sterility is a required quality standard for injectable products. This recall indicates the manufacturer cannot assure that the product meets the FDA's sterility requirements.
The recalled product
- Product
- TEST CYP/DHEA (Sesame) 200 MG/2.5 MG/ML Injectable, 10 ML vial, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.
- Manufacturer
- Carolina Infusion
- Category
- Drug — Injectable Steroid
- Affected units
- 348
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (20)
- Lots: 06012022@1
- 06012022@2 BUD: 08/30/2022
- 06032022@1
- 06032022@2
- 06032022@13 BUD: 09/01/2022
- 06062022@7
- BUD: 09/04/2022
- 06072022@3
- 06072022@4 BUD: 09/05/2022
- 06082022@1
- 06082022@2
- 06082022@4 BUD: 09/06/2022
- 06102022@8
- BUD: 09/08/2022
- 09/11/2022
- 06132022@1
- 06132022@7
- 06132022@14
- 06132022@15
- BUD: 09/11/2022
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 20 recalled by Carolina Infusion under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 20 products in this recall →Related recalls
Same manufacturer · Carolina Infusion
See all →- HighInjectable drug product recalled for lack of sterility assurance
FDA (Drugs) · 2022-09-21
- HighInjectable testosterone product recalled for sterility assurance defect
FDA (Drugs) · 2022-09-21
- HighInjectable Medication TRI-MIX Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighSermorelin Acetate Injectable Recalled Due to Lack of Sterility Assurance
FDA (Drugs) · 2022-09-21
- HighTRI-MIX 30/1/40 Injectable Recalled Due to Lack of Sterile Assurance
FDA (Drugs) · 2022-09-21
Same hazard · sterility defect
See all →- SevereLidocaine Hydrochloride Injection Recalled for Sterility Assurance
FDA (Drugs) · 2026-07-08
- SevereIMULDOSA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-08
- HighChloraPrep One-Step antiseptic solution sterility assurance recall
FDA (Drugs) · 2026-07-01
- ModerateCodman CerebroFlo EVD Catheter recalled for out-of-specification endotoxin
FDA (Devices) · 2026-05-20
- HighMedline Medical Procedure Kits with Neuro Sponges Recalled for Endotoxin
FDA (Devices) · 2026-05-06